OnKure Therapeutics, Inc. of BOULDER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-08. The offering totals $52.0M, of which $22.0M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 30 people.
| Name | Role | Location |
|---|---|---|
| Niall O'Donnell | Director | St. Louis, MO |
| Scott Weiner | Director | New York, NY |
| Michael Grey | Executive Officer | South San Francisco, CA |
| Niall O'Donnell | Executive Officer | St. Louis, MO |
| Bali Muralidhar | Director | St. Louis, MO |
| Michael Grey | Director | South San Francisco, CA |
| Kenneth Harrison | Director | Half Moon Bay, CA |
| Isaac M Manke | Director | Boulder, CO |
| Jason Leverone | Executive Officer | Boulder, CO |
| Samuel Agresta | Executive Officer | Boulder, CO |
| Dylan Hartley | Executive Officer | Boulder, CO |
| Nicholas Saccomano | Director | Boulder, CO |
| Nicholas Saccomano | Executive Officer | Boulder, CO |
| Valerie M Jansen | Director | Boulder, CO |
| R. Michael Carruthers | Director | Boulder, CO |
| Michael G Grey | Director | Boulder, CO |
| Andrew Johm Phillips | Director | Boulder, CO |
| Gregory Flesher | Director | San Diego, CA |
| Gregory Flesher | Executive Officer | San Diego, CA |
| Lon Cardon, Ph.D. | Director | San Diego, CA |
| Johan Kordel, Ph.D. | Director | San Diego, CA |
| Ed Mathers | Director | TIMONIUM, MD |
| Niall O'Donnell, Ph.D. | Director | San Diego, CA |
| Niall O'Donnell, Ph.D. | Executive Officer | San Diego, CA |
| Wendy Johnson | Executive Officer | San Diego, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-10-21 | D | $65.0M | $65.0M |
| 2020-12-21 | D | $94.8M | $47.4M |
| 2019-05-14 | D | $25.0M | $25.0M |